Association of genetic polymorphisms in the ACE, ApoE, and TGFβ genes with early onset ischemic heart disease

Clinical Cardiology

Volumn 21, Issue 11, 1998, Pages 831-836

  Biggart, S ^a   Chin, D ^b   Fauchon, M ^c   Cardew, G ^c   Du Fou, L ^c   Harker, N ^c   Quinn, E ^d   Keller, C ^d   Vincent, R ^d   Mayne, L ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

^d ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Angiotensin converting enzyme; Apolipoprotein E; DNA polymorphisms; Ischemic heart disease; Transforming growth factor 2

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; HEART DEVELOPMENT; HEREDITY; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 0031760027     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960211109     Document Type: Article

References (22)

1. Cambien F, Poirier O, Lecerf L, Evans A, Cambous J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644
2. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, Banchieri N, Fortina P, Danesino C, Specchia G: Angiotensin-converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J 1995;74:584-591
3. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K: Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 1993;44:292-297
4. Gardemann A, Weiss T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, Tillmanns H, Waas W, Haberbosch W: Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 1995;92:2796-2799
5. Ludwig E, Cornell PS, Anderson JL, Marshall HW, Lalouel J-M, Ward RH: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronory stenosis. Circulation 1995;91:2120-2124
6. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O'Rourke DF, Cambien F: Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Quart J Med 1994;87:211-214
7. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F: A deletion polymorphism in the angiotensin-converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995;112:137-143
8. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien F: Synergistic effects of angiotensin-converting enzyme and angiotensin-II type I receptor gene polymorphisms on risk of myocardial infarcation. Lancet 1994;344:910-913
9. Jeunemaitre X, Ledru F, Battaglia S, Guillanneuf MT, Courbon D, Dumont C, Darmon O, Guize L, Guermonprez JL, Diebold B, Ducimetiere P: Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: The Corgene Study. Hum Genet 1997;99:66-73
10. Menzel H-J, Kladetzky R-G, Assmann G: Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983;3: 310-315
11. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21
12. Humphries SE: DNA polymorphisms of the apolipoprotein genes -their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Atherosclerosis 1988;72:89-108
13. Dickson MC, Slager HG, Duffie E, Mummery CL, Akhurst RJ: RNA and protein localisations of TGF beta 2 in the early mouse embryo suggest an involvement in cardiac development. Development 1993;117:625-639
14. WHO MONICA Project: MONICA Manual. Geneva: Cardiovascular Diseases Unit, World Health Organisation, 1990
15. WHO/ISH 1993 Guidelines for the Management of Mild Hypertension. Bulletin of the World Health Organization (1993) 71(5): 503-517
16. WHO Guidelines for Diabetes Mellitus, p, 727. Geneva: WHO, 1985
17. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning, a Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989
18. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1), Nucl Acids Res 1992;20:1433
19. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein PHF, LaMotte F, Buring J, Hennekens CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711
20. Thun MJ, Daylally CA, Calle EE, Flanders WD, Heath CW: Excess mortality among cigarette smokers - changes in a 20-year interval. Am J Pub/Health 1995;85:1223-1230
21. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M: A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995;91:270-274
22. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO, Sagnella GA: Angiotensin-converting enzyme insertion/deletion polymorphism: Association with. J Hypertens 1994;12:955-957